AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
EFFECT OF BISMUTH-THIOL COMBINATION ON SURVIVAL IN SEPTIC MICE
Authors: GLUCK JA SAHA DC RACKOW EC ASTIZ ME DOMENICO P
Citation: Ja. Gluck et al., EFFECT OF BISMUTH-THIOL COMBINATION ON SURVIVAL IN SEPTIC MICE, Journal of investigative medicine, 46(1), 1998, pp. 42-42
EFFECT OF BISMUTH-ETHANEDITHIOL ON REACTIVE RADICAL RELEASE BY SPLENIC MACROPHAGES IN SEPSIS
Authors: SAHA DC GLUCK JA RACKOW EC ASTIZ ME DOMENICO P
Citation: Dc. Saha et al., EFFECT OF BISMUTH-ETHANEDITHIOL ON REACTIVE RADICAL RELEASE BY SPLENIC MACROPHAGES IN SEPSIS, Journal of investigative medicine, 46(1), 1998, pp. 98-98
INTERPRETATION OF BLOOD LACTATE CONCENTRATIONS IN PATIENTS WITH SEPSIS
Authors: KIRSCHENBAUM LA ASTIZ ME RACKOW EC
Citation: La. Kirschenbaum et al., INTERPRETATION OF BLOOD LACTATE CONCENTRATIONS IN PATIENTS WITH SEPSIS, Lancet, 352(9132), 1998, pp. 921-922
SEPTIC SHOCK
Authors: ASTIZ ME RACKOW EC
Citation: Me. Astiz et Ec. Rackow, SEPTIC SHOCK, Lancet, 351(9114), 1998, pp. 1501-1505
ANTIBODIES TO TNF-ALPHA - TOO LITTLE, TOO LATE
Authors: KIRSCHENBAUM L ASTIZ M RACKOW EC
Citation: L. Kirschenbaum et al., ANTIBODIES TO TNF-ALPHA - TOO LITTLE, TOO LATE, Critical care medicine, 26(10), 1998, pp. 1625-1626
EFFECTS OF PROINFLAMMATORY CYTOKINES AND BACTERIAL TOXINS ON NEUTROPHIL THEOLOGICAL PROPERTIES
Authors: LAVKAN AH ASTIZ ME RACKOW EC
Citation: Ah. Lavkan et al., EFFECTS OF PROINFLAMMATORY CYTOKINES AND BACTERIAL TOXINS ON NEUTROPHIL THEOLOGICAL PROPERTIES, Critical care medicine, 26(10), 1998, pp. 1677-1682
NEUTROPHIL RHEOLOGIC CHANGES IN SEPTIC SHOCK
Authors: YODICE PC ASTIZ ME KURIAN BM LIN RY RACKOW EC
Citation: Pc. Yodice et al., NEUTROPHIL RHEOLOGIC CHANGES IN SEPTIC SHOCK, American journal of respiratory and critical care medicine, 155(1), 1997, pp. 38-42
EFFECT OF CRYSTALLOID AND COLLOID SOLUTIONS ON BLOOD RHEOLOGY IN SEPSIS
Authors: CASTRO VJ ASTIZ ME RACKOW EC
Citation: Vj. Castro et al., EFFECT OF CRYSTALLOID AND COLLOID SOLUTIONS ON BLOOD RHEOLOGY IN SEPSIS, Shock, 8(2), 1997, pp. 104-107
MONOPHOSPHORYL LIPID-A STIMULATED UP-REGULATION OF NITRIC-OXIDE SYNTHASE AND NITRIC-OXIDE RELEASE BY HUMAN MONOCYTES IN-VITRO
Authors: SAHA DC ASTIZ ME LIN RY RACKOW EC EALES LJ
Citation: Dc. Saha et al., MONOPHOSPHORYL LIPID-A STIMULATED UP-REGULATION OF NITRIC-OXIDE SYNTHASE AND NITRIC-OXIDE RELEASE BY HUMAN MONOCYTES IN-VITRO, Immunopharmacology, 37(2-3), 1997, pp. 175-184
PULMONARY-ARTERY-CATHETER-CONSENSUS-CONFERENCE
Authors: RACKOW EC
Citation: Ec. Rackow, PULMONARY-ARTERY-CATHETER-CONSENSUS-CONFERENCE, Critical care medicine, 25(6), 1997, pp. 901-901
OPTIMIZING GASTRIC-MUCOSAL PERFUSION - ALL CATECHOLAMINES MAY NOT BE CREATED EQUAL
Authors: CARPATI CM ASTIZ ME RACKOW EC
Citation: Cm. Carpati et al., OPTIMIZING GASTRIC-MUCOSAL PERFUSION - ALL CATECHOLAMINES MAY NOT BE CREATED EQUAL, Critical care medicine, 25(10), 1997, pp. 1624-1625
RELATIONSHIPS BETWEEN PHAGOCYTOSIS, IL-10, G-CSF AND NITRIC-OXIDE PRODUCTION IN-VITRO BY HUMAN MONOCYTES
Authors: SAHA DC AHMED S ASTIZ ME LIN RY RACKOW EC EALES LJ
Citation: Dc. Saha et al., RELATIONSHIPS BETWEEN PHAGOCYTOSIS, IL-10, G-CSF AND NITRIC-OXIDE PRODUCTION IN-VITRO BY HUMAN MONOCYTES, Journal of investigative medicine, 44(1), 1996, pp. 158-158
THE AMERICAN-BOARD-OF-INTERNAL-MEDICINE RECERTIFICATION PROGRAM - NEARING LIFTOFF
Authors: RACKOW EC
Citation: Ec. Rackow, THE AMERICAN-BOARD-OF-INTERNAL-MEDICINE RECERTIFICATION PROGRAM - NEARING LIFTOFF, Critical care medicine, 24(5), 1996, pp. 888-889
USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS
Authors: KNAUS WA HARRELL FE LABRECQUE JF WAGNER DP PRIBBLE JP DRAPER EA FISHER CJ SOLL L ASTIZ M RACKOW EC CARPATI C BALK RA FRIEDMAN B MURE AJ SHAPIRO E MELHOM L SHAPIRO MJ TAYLOR R KEEGAN M OBRIEN J GREENMAN RL SCHEIN R PENA M WASSERLOUF M IBERTI TJ OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAN N MERRICK DK BERQUIST W MATZEL K HUEBLER M FOULKE G ALBERTSON T WALBY W ALLEN R BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMAS BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C GERVICH D BRASE R BAGDAHN A COONEY R SMITH JS VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN H DURKIN M STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUVEN PAM BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL J KRUGER R DRUMMOND A FISHER CS LANGE P SELFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY S COYLE SM BARIE PS DEMARIA E REINES HD SNYDMAN D SCHWAITZBERG S NASRAWAY S GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D BLEICHNER G DAHN M HALL J WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J SHELLY MP NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON G SENEFF M CONRY K ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D LAURELL MH JACOBS S ASH S OPAL SM SLOTMAN GJ IBERTI TJ SADOFF JC STILES DM THOMPSON B PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDMAN H WITTES J THOMPSON BW LABRECQUE JF CATALANO MA CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Wa. Knaus et al., USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS, Critical care medicine, 24(1), 1996, pp. 46-56
THE PATTERN OF INFLAMMATION IN RAT SEPSIS DUE TO ENTEROTOXIN-PRODUCING STAPHYLOCOCCUS-AUREUS - A COMPARISON WITH ISCHEMIA-REPERFUSION INJURY
Authors: LIN RY SAHA DC BERNSTEIN CJ ASTIZ ME RACKOW EC
Citation: Ry. Lin et al., THE PATTERN OF INFLAMMATION IN RAT SEPSIS DUE TO ENTEROTOXIN-PRODUCING STAPHYLOCOCCUS-AUREUS - A COMPARISON WITH ISCHEMIA-REPERFUSION INJURY, Journal of medicine, 27(5-6), 1996, pp. 303-317
NON-ICU CARE OF HEMODYNAMICALLY STABLE MECHANICALLY VENTILATED PATIENTS
Authors: LATRIANO B MCCAULEY P ASTIZ ME GREENBAUM D RACKOW EC
Citation: B. Latriano et al., NON-ICU CARE OF HEMODYNAMICALLY STABLE MECHANICALLY VENTILATED PATIENTS, Chest, 109(6), 1996, pp. 1591-1596
MICROVASCULAR FUNCTION AND THEOLOGICAL CHANGES IN HYPERDYNAMIC SEPSIS
Authors: ASTIZ ME DEGENT GE LIN RY RACKOW EC
Citation: Me. Astiz et al., MICROVASCULAR FUNCTION AND THEOLOGICAL CHANGES IN HYPERDYNAMIC SEPSIS, Critical care medicine, 23(2), 1995, pp. 265-271
MONOPHOSPHORYL LIPID A AND ENDOTOXIN TOLERANCE - REPLY
Authors: ASTIZ ME RACKOW EC
Citation: Me. Astiz et Ec. Rackow, MONOPHOSPHORYL LIPID A AND ENDOTOXIN TOLERANCE - REPLY, Critical care medicine, 23(10), 1995, pp. 1789-1790
PRETREATMENT OF NORMAL HUMANS WITH MONOPHOSPHORYL LIPID-A INDUCES TOLERANCE TO ENDOTOXIN - A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL
Authors: ASTIZ ME RACKOW EC STILL JG HOWELL ST CATO A VONESCHEN KB ULRICH JT RUDBACH JA MCMAHON G VARGAS R STERN W
Citation: Me. Astiz et al., PRETREATMENT OF NORMAL HUMANS WITH MONOPHOSPHORYL LIPID-A INDUCES TOLERANCE TO ENDOTOXIN - A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL, Critical care medicine, 23(1), 1995, pp. 9-17
MONOPHOSPHORYL LIPID-A PROTECTS AGAINST GRAM-POSITIVE SEPSIS AND TUMOR-NECROSIS-FACTOR
Authors: ASTIZ ME GALERA A SAHA DC CARPATI C RACKOW EC
Citation: Me. Astiz et al., MONOPHOSPHORYL LIPID-A PROTECTS AGAINST GRAM-POSITIVE SEPSIS AND TUMOR-NECROSIS-FACTOR, Shock, 2(4), 1994, pp. 271-274
COMBINING THE 4TH YEAR OF MEDICAL-SCHOOL WITH THE 1ST YEAR OF AN INTERNAL-MEDICINE RESIDENCY
Authors: GRAYSON MS RACKOW EC ADLER KP
Citation: Ms. Grayson et al., COMBINING THE 4TH YEAR OF MEDICAL-SCHOOL WITH THE 1ST YEAR OF AN INTERNAL-MEDICINE RESIDENCY, Academic medicine, 69(5), 1994, pp. 423-424
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME (VOL 271, PG 1836, 1994)
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME (VOL 271, PG 1836, 1994), JAMA, the journal of the American Medical Association, 272(15), 1994, pp. 1170-1170
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC ASTIZ M CARPATI C BONE RC FREIDMAN B MURE AJ BRATHWAITE C SHAPIRO E MELHORN L TAYLOR R KEEGAN M OBRIEN J SCHEIN R PENA M WASSERLOUF M OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAM N MERRICK DK BERGQUIST W MATZEL KE HUEBLER M FOULKE GE ALBERTSON TE WALBY WF ALLEN RP BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMPSON BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C STORER S GERVICH DH FOSHE D BRASE R BAGDAHN A COONEY R SMITH JS MARTIN LF VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN HG DURKIN MR DUBIN PK STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUWEN PAM BOERMEESTER MA SCHNEIDER AJ BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N SILVERSTEIN J ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL JA KRUGER R DRUMMOND A LANGE P SEIFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY SF COYLE SM BARIE PS DEMARIA E SNYDMAN DR SCHWAITZBERG SD NASRAWAY SA GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D CAMPBELL D BLEICHNER G DAHN MS LANGE MPA HALL J POHLMAN A WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON GL SENEFF MG CONRY KM ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D PORTER JC LAURELL MH JACOBS S ASH S STILES DM PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDEMAN H WITTES J CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 271(23), 1994, pp. 1836-1843
RELATIONSHIPS BETWEEN PLASMA CYTOKINE CONCENTRATIONS AND LEUKOCYTE FUNCTIONAL ANTIGEN EXPRESSION IN PATIENTS WITH SEPSIS
Authors: LIN RY ASTIZ ME SAXON JC SAHA DC RACKOW EC
Citation: Ry. Lin et al., RELATIONSHIPS BETWEEN PLASMA CYTOKINE CONCENTRATIONS AND LEUKOCYTE FUNCTIONAL ANTIGEN EXPRESSION IN PATIENTS WITH SEPSIS, Critical care medicine, 22(10), 1994, pp. 1595-1602
INCREASED VENOUS-ARTERIAL CARBON-DIOXIDE TENSION DIFFERENCE DURING SEVERE SEPSIS IN RATS
Authors: RACKOW EC ASTIZ ME MECHER CE WEIL MH
Citation: Ec. Rackow et al., INCREASED VENOUS-ARTERIAL CARBON-DIOXIDE TENSION DIFFERENCE DURING SEVERE SEPSIS IN RATS, Critical care medicine, 22(1), 1994, pp. 121-125
Risultati: 1-25 | 26-31